
uniQure NV Faces Weak Start with 5.08% Gap Down Amid Market Concerns
2025-11-21 16:07:03uniQure NV, a small-cap biotechnology firm, experienced a notable decline in its stock performance today, reflecting a significant downturn over the past month. Technical indicators present a mixed outlook, with contrasting signals from MACD and Bollinger Bands. The company's financial metrics reveal a complex situation for stakeholders.
Read full news article
uniQure NV Hits Day High with 15.18% Surge Amid Market Volatility
2025-11-13 16:29:42uniQure NV's stock surged significantly today, contrasting with the modest rise of the S&P 500. Despite recent challenges, including a decline over the past week and month, the company has achieved impressive one-year returns. However, it faces operational difficulties, including negative EBITDA and debt servicing issues.
Read full news article
uniQure NV Hits Day High with 17.93% Surge Amid Strong Intraday Performance
2025-11-12 16:35:26uniQure NV, a small-cap biotechnology firm, saw a notable intraday gain today, contrasting with the S&P 500's modest rise. Despite a remarkable annual return, the company faces significant challenges, including operating losses, declining net sales, and a negative EBITDA, raising concerns about its financial stability.
Read full news article





